Insider Transactions

What First Tracks Biotherapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	1	2
Total trades	8	10

Shares traded

	3 months	12 months
Acquired	76,745	4,782,320
Disposed	39,265	39,265
Net activity	+37,480	+4,743,055

Common stock only — 1 reported trade in the last 12 months is in a security these totals do not cover.

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Ware J. Anthony	Director	Sep 02	Open-market sale · S	−39,265	$44.78	−$1.76M	15,660
Ware J. Anthony	Director	Sep 02	Exercise / conversion · M	+39,265	$5.74	+$225K	54,925
Fenton Dennis M	Director	Jun 15	Exercise / conversion · M	+6,030	—	—	10,995
Orwin John A	Director	Jun 15	Exercise / conversion · M	+6,030	—	—	16,695
Schmid John P.	Director	Jun 15	Exercise / conversion · M	+6,030	—	—	37,652
Marquet Magda	Director	Jun 15	Exercise / conversion · M	+6,030	—	—	15,960
Jain Rita	Director	Jun 15	Exercise / conversion · M	+7,330	—	—	19,194
Ware J. Anthony	Director	Jun 15	Exercise / conversion · M	+6,030	—	—	15,660
EcoR1 Capital, Llc	10% owner	Apr 20	Open-market sale · S	+4,705,575	$13.81	+$65M	3,174,519
ANAPTYSBIO, Inc	10% owner	Apr 20	Other Transaction · J	−100	—	—	0

Page 1 of 1 · showing the 10 most recent Sign up free to view all 10 transactions and filter by insider →